Sallam M, Khalil R
Microorganisms. 2024; 12(6).
PMID: 38930417
PMC: 11205832.
DOI: 10.3390/microorganisms12061035.
Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Yepez Guevara E
Am J Gastroenterol. 2023; 118(9):1609-1617.
PMID: 37307533
PMC: 11809494.
DOI: 10.14309/ajg.0000000000002361.
Osuch S, Laskus T, Perlejewski K, Berak H, Bukowska-Osko I, Pollak A
Front Immunol. 2022; 13:832206.
PMID: 35386708
PMC: 8977521.
DOI: 10.3389/fimmu.2022.832206.
Elsheikh M, McClure C, Tarr A, Irving W
J Gen Virol. 2022; 103(3).
PMID: 35230930
PMC: 9176264.
DOI: 10.1099/jgv.0.001727.
Colon-Moran W, Baer A, Lamture G, Stapleton J, Fischer J, Bhattarai N
Gene Ther. 2021; 29(10-11):616-623.
PMID: 34759330
PMC: 9091046.
DOI: 10.1038/s41434-021-00302-5.
Reversal of T Cell Exhaustion in Chronic HCV Infection.
Osuch S, Metzner K, Caraballo Cortes K
Viruses. 2020; 12(8).
PMID: 32722372
PMC: 7472290.
DOI: 10.3390/v12080799.
Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer: A systematic review.
Pu D, Yin L, Zhou Y, Li W, Huang L, Cai L
Medicine (Baltimore). 2020; 99(5):e19013.
PMID: 32000444
PMC: 7004734.
DOI: 10.1097/MD.0000000000019013.
Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population.
Stevens E, Nucifora K, Hagan H, Jordan A, Uyei J, Khan B
Clin Infect Dis. 2019; 70(12):2652-2662.
PMID: 31400755
PMC: 7286369.
DOI: 10.1093/cid/ciz726.
High prevalence of occult hepatitis C infection in predialysis patients.
Sette L, Lopes E, Guedes Dos Anjos N, Valente L, de Oliveira S, Lucena-Silva N
World J Hepatol. 2019; 11(1):109-118.
PMID: 30705723
PMC: 6354127.
DOI: 10.4254/wjh.v11.i1.109.
Aminoacyl-tRNA synthetases, therapeutic targets for infectious diseases.
Lee E, Kim S, Kim M
Biochem Pharmacol. 2018; 154:424-434.
PMID: 29890143
PMC: 7092877.
DOI: 10.1016/j.bcp.2018.06.009.
Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center.
Caraballo Cortes K, Rosinska M, Janiak M, Stepien M, Zagordi O, Perlejewski K
PLoS One. 2018; 13(3):e0194816.
PMID: 29566084
PMC: 5864040.
DOI: 10.1371/journal.pone.0194816.
Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation Sequencing.
Caraballo Cortes K, Zagordi O, Jablonska J, Pawelczyk A, Kubisa N, Perlejewski K
PLoS One. 2016; 11(2):e0150311.
PMID: 26918636
PMC: 4769329.
DOI: 10.1371/journal.pone.0150311.
Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.
Rosen A, Casciola-Rosen L
Annu Rev Immunol. 2016; 34:395-420.
PMID: 26907212
PMC: 6547816.
DOI: 10.1146/annurev-immunol-032414-112205.
PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.
Xiao W, Jiang L, Deng X, Zhu D, Pei J, Xu M
Immunol Res. 2015; 64(2):412-23.
PMID: 26286967
DOI: 10.1007/s12026-015-8680-y.
Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function.
Chivero E, Bhattarai N, McLinden J, Xiang J, Stapleton J
Virology. 2015; 485:116-27.
PMID: 26245365
PMC: 5744589.
DOI: 10.1016/j.virol.2015.07.008.
Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.
Chivero E, Stapleton J
J Gen Virol. 2015; 96(Pt 7):1521-32.
PMID: 25667328
PMC: 5744597.
DOI: 10.1099/vir.0.000086.
Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure.
Urbaczek A, Ribeiro L, Ximenes V, Afonso A, Nogueira C, Generoso W
Mem Inst Oswaldo Cruz. 2014; 109(6):748-56.
PMID: 25317702
PMC: 4238766.
DOI: 10.1590/0074-0276140090.
Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.
Kuniholm M, Xie X, Anastos K, Kaplan R, Xue X, Kovacs A
J Acquir Immune Defic Syndr. 2014; 67(3):295-303.
PMID: 25314250
PMC: 4197408.
DOI: 10.1097/QAI.0000000000000310.
Hepatitis C virus infection in the human immunodeficiency virus infected patient.
Clausen L, Lundbo L, Benfield T
World J Gastroenterol. 2014; 20(34):12132-43.
PMID: 25232248
PMC: 4161799.
DOI: 10.3748/wjg.v20.i34.12132.
In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello J, Lallos L, McCarville J, La Colla M, Serra I, Chapron C
Antimicrob Agents Chemother. 2014; 58(8):4431-42.
PMID: 24867983
PMC: 4136001.
DOI: 10.1128/AAC.02777-13.